Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by OldYinon Jun 20, 2017 7:27am

391 Views

Post# 26381206

Globe: retail push this a.m.?

Close: $1.84, up 19¢

ProMetic Life Sciences Inc.’s $53million equity financing is dilute, but it strengthens its balance sheet, according to Canaccord Genuity analyst Neil Maruoka. However, citing the dilution resulting from the financing and near-term uncertainty related to its plasminogen treatment, Mr. Maruoka lowered his target and removed ProMetic from Canaccord’s Canadian Focus List.